Skip to main content
TRAX
NASDAQ Life Sciences

Q3 Net Loss Narrows to $31.4M as First Tracks Lays Out 2027 Data Calendar

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Neutral
Importance info
7
Price
$46.34
Mkt Cap
$1.947B
52W Low
$14.72
52W High
$49.911
52W Position info
215% above low
Off High info
7.2% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

TRAX has more than doubled off its 52-week low of $14.72.

Summary

First Tracks posted a Q3 net loss of $31.4 million, or $0.88 a share, versus $41.9 million a year earlier, with R&D down to $23.8 million from $33.3 million as rosnilimab and ANB032 spending fell. Cash and investments stood at $155.6 million on Sept. 30, and the $200 million private placement closed in October lifts pro forma cash to $343 million — funding well past the 2027 readouts. The pipeline calendar is the real content: Cohort 2 celiac mucosal-healing data now expected Q1 2027, EoE Phase 1b top-line Q3 2027, and Phase 2 starts in vitiligo plus one more indication in H1 2027, all building on the positive October Cohort 1 gluten-challenge results. Rosnilimab is the soft spot — management is only 'assessing strategic options' to advance it, which reads as deprioritized. Q1 2027 Cohort 2 data is the next binary event for the celiac thesis.

At the time of this announcement, TRAX was trading at $46.34 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $14.72 to $49.91. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

TRAX - Latest Insights

TRAX
Oct 15, 2026, 4:28 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $36.50
Real-time Price: $45.00 info
Change: +$8.50 (+23%) info
Market Cap: $1.868B info
TRAX
Oct 15, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $34.98
Real-time Price: $45.00 info
Change: +$10.02 (+29%) info
Market Cap: $1.868B info
TRAX
Oct 12, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $36.49
Real-time Price: $45.00 info
Change: +$8.51 (+23%) info
Market Cap: $1.868B info
TRAX
Aug 12, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $45.75
Real-time Price: $45.00 info
Change: -$0.750 (-2%) info
Market Cap: $1.868B info
TRAX
Aug 12, 2026, 4:15 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $45.75
Real-time Price: $45.00 info
Change: -$0.750 (-2%) info
Market Cap: $1.868B info